(NASDAQ: GBIO) Generation Bio Co's forecast annual revenue growth rate of -5.77% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Generation Bio Co's revenue in 2024 is $5,904,000.On average, 1 Wall Street analysts forecast GBIO's revenue for 2024 to be $858,884,274, with the lowest GBIO revenue forecast at $858,884,274, and the highest GBIO revenue forecast at $858,884,274. On average, 1 Wall Street analysts forecast GBIO's revenue for 2025 to be $404,180,835, with the lowest GBIO revenue forecast at $404,180,835, and the highest GBIO revenue forecast at $404,180,835.
In 2026, GBIO is forecast to generate $404,180,835 in revenue, with the lowest revenue forecast at $404,180,835 and the highest revenue forecast at $404,180,835.